Cargando…
Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118251/ https://www.ncbi.nlm.nih.gov/pubmed/31221707 http://dx.doi.org/10.2337/dc18-1578 |
| _version_ | 1783514521606815744 |
|---|---|
| author | Li, Guangyao Crowley, Matthew J. Tang, Huilin Yang, Jeff Y. Sandler, Robert S. Wang, Tiansheng |
| author_facet | Li, Guangyao Crowley, Matthew J. Tang, Huilin Yang, Jeff Y. Sandler, Robert S. Wang, Tiansheng |
| author_sort | Li, Guangyao |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7118251 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71182512020-07-01 Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials Li, Guangyao Crowley, Matthew J. Tang, Huilin Yang, Jeff Y. Sandler, Robert S. Wang, Tiansheng Diabetes Care e-Letters: Observations American Diabetes Association 2019-07 2019-05-21 /pmc/articles/PMC7118251/ /pubmed/31221707 http://dx.doi.org/10.2337/dc18-1578 Text en © 2019 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license. |
| spellingShingle | e-Letters: Observations Li, Guangyao Crowley, Matthew J. Tang, Huilin Yang, Jeff Y. Sandler, Robert S. Wang, Tiansheng Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials |
| title | Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials |
| title_full | Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials |
| title_fullStr | Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials |
| title_full_unstemmed | Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials |
| title_short | Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials |
| title_sort | dipeptidyl peptidase 4 inhibitors and risk of inflammatory bowel disease among patients with type 2 diabetes: a meta-analysis of randomized controlled trials |
| topic | e-Letters: Observations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118251/ https://www.ncbi.nlm.nih.gov/pubmed/31221707 http://dx.doi.org/10.2337/dc18-1578 |
| work_keys_str_mv | AT liguangyao dipeptidylpeptidase4inhibitorsandriskofinflammatoryboweldiseaseamongpatientswithtype2diabetesametaanalysisofrandomizedcontrolledtrials AT crowleymatthewj dipeptidylpeptidase4inhibitorsandriskofinflammatoryboweldiseaseamongpatientswithtype2diabetesametaanalysisofrandomizedcontrolledtrials AT tanghuilin dipeptidylpeptidase4inhibitorsandriskofinflammatoryboweldiseaseamongpatientswithtype2diabetesametaanalysisofrandomizedcontrolledtrials AT yangjeffy dipeptidylpeptidase4inhibitorsandriskofinflammatoryboweldiseaseamongpatientswithtype2diabetesametaanalysisofrandomizedcontrolledtrials AT sandlerroberts dipeptidylpeptidase4inhibitorsandriskofinflammatoryboweldiseaseamongpatientswithtype2diabetesametaanalysisofrandomizedcontrolledtrials AT wangtiansheng dipeptidylpeptidase4inhibitorsandriskofinflammatoryboweldiseaseamongpatientswithtype2diabetesametaanalysisofrandomizedcontrolledtrials |